{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:44:28Z","timestamp":1792449868616,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ijantimicag.2012.10.023","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T23:34:07Z","timestamp":1357688047000},"page":"272-277","source":"Crossref","is-referenced-by-count":43,"title":["Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey"],"prefix":"10.1016","volume":"41","author":[{"given":"Jonas","family":"Marschall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Beekmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Polgreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary M.","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0005","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/508456","article-title":"Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an Emerging Infections Network survey","volume":"43","author":"Chary","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0010","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.arth.2007.10.017","article-title":"Infection burden for hip and knee arthroplasty in the United States","volume":"23","author":"Kurtz","year":"2008","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0015","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2106\/JBJS.I.01199","article-title":"Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis","volume":"92","author":"Berbari","year":"2010","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","article-title":"Systematic review and meta-analysis of antibiotic therapy for bone and joint infections","volume":"1","author":"Stengel","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0025","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","article-title":"Prosthetic-joint infections","volume":"351","author":"Zimmerli","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl. 4","key":"10.1016\/j.ijantimicag.2012.10.023_bib0030","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.ijid.2010.05.005","article-title":"Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections","volume":"14","author":"Leone","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijantimicag.2012.10.023_bib0035","first-page":"CD004439","article-title":"Antibiotics for treating chronic osteomyelitis in adults","author":"Conterno","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-10-18","article-title":"What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients","volume":"10","author":"Beswick","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1086\/514511","article-title":"The Emerging Infections Network: a new venture for the Infectious Diseases Society of America. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network","volume":"25","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0050","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s11999-012-2434-0","article-title":"Culture-negative periprosthetic joint infection does not preclude infection control","volume":"470","author":"Huang","year":"2012","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2012.10.023_bib0055","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1111\/j.1444-0903.2005.00982.x","article-title":"Management of bone and joint infections due to Staphylococcus aureus","volume":"35","author":"Davis","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0060","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1128\/AAC.00389-08","article-title":"Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations","volume":"53","author":"Zeller","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2334-11-279","article-title":"Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia","volume":"11","author":"Schweizer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/cid\/cir857","article-title":"A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureus","volume":"54","author":"Wieland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jac\/dkm437","article-title":"Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia","volume":"61","author":"Lalani","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jinf.2007.02.006","article-title":"Propionibacterium acnes: an agent of prosthetic joint infection and colonization","volume":"55","author":"Zeller","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0085","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00402-007-0454-0","article-title":"Propionibacterium spp. in prosthetic joint infections: a diagnostic challenge","volume":"128","author":"Zappe","year":"2008","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0090","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11999-010-1338-0","article-title":"Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection","volume":"468","author":"Malekzadeh","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/JCM.00170-11","article-title":"Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection","volume":"50","author":"Marin","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nrrheum.2011.128","article-title":"Mediators of the inflammatory response to joint replacement devices","volume":"7","author":"Cobelli","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0105","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10096-010-0952-9","article-title":"Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention","volume":"29","author":"El Helou","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0115","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1469-0691.2005.01230.x","article-title":"Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections","volume":"11","author":"Berdal","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0120","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1128\/AAC.00226-10","article-title":"Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus","volume":"54","author":"Garrigos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0125","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/jac\/dkr182","article-title":"Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection","volume":"66","author":"Bejon","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1574-695X.2012.00938.x","article-title":"Pathogenesis and treatment concepts of orthopaedic biofilm infections","volume":"65","author":"Zimmerli","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.idc.2011.09.011","article-title":"Management and prevention of prosthetic joint infection","volume":"26","author":"Shuman","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0140","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/529436","article-title":"Treatment of joint prosthesis infection in accordance with current recommendations improves outcome","volume":"46","author":"Betsch","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/IPC.0b013e31816d2118","article-title":"Suppressive antibiotic therapy for retained infected prosthetic joints. Case series and review of the literature","volume":"16","author":"Koeppe","year":"2008","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2012.10.023_bib0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.diagmicrobio.2009.08.016","article-title":"Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey","volume":"66","author":"Johannsson","year":"2010","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912004438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T23:13:06Z","timestamp":1562541186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912004438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0924857912004438"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.10.023","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}